國立虎尾科技大學 |

登入

回首頁

Targeting the IL-17 pathway in infla...

SpringerLink (Online service)

Targeting the IL-17 pathway in inflammatory disorders

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Targeting the IL-17 pathway in inflammatory disorders/ by Cong-Qiu Chu.
作者:	Chu, Cong-Qiu.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	xv, 102 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Interleukins. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-28040-0
ISBN:	9783319280400

Targeting the IL-17 pathway in inflammatory disorders
Chu, Cong-Qiu.

Targeting the IL-17 pathway in inflammatory disorders[electronic resource] /by Cong-Qiu Chu. - Cham :Springer International Publishing :2017. - xv, 102 p. :ill., digital ;24 cm.

This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.

ISBN: 9783319280400

Standard No.: 10.1007/978-3-319-28040-0doiSubjects--Topical Terms:

1028088
Interleukins.

LC Class. No.: QR185.8.I56

Dewey Class. No.: 571.96

Targeting the IL-17 pathway in inflammatory disorders
LDR:01685nam a2200301 a 4500 001 957366
003 DE-He213
005 20161128200532.0
006 m d
007 cr nn 008maaau
008 201118s2017 gw s 0 eng d
020 $a 9783319280400 $q (electronic bk.)
020 $a 9783319280394 $q (paper)
024 7 $a 10.1007/978-3-319-28040-0 $2 doi
035 $a 978-3-319-28040-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QR185.8.I56
072 7 $a MJM $2 bicssc
072 7 $a MED083000 $2 bisacsh
082 0 4 $a 571.96 $2 23
090 $a QR185.8.I56 $b C559 2017
100 1 $a Chu, Cong-Qiu. $3 1248919
245 1 0 $a Targeting the IL-17 pathway in inflammatory disorders $h [electronic resource] / $c by Cong-Qiu Chu.
260 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2017.
300 $a xv, 102 p. : $b ill., digital ; $c 24 cm.
520 $a This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
650 0 $a Interleukins. $3 1028088
650 0 $a Inflammation. $3 583465
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Rheumatology. $3 668542
650 2 4 $a Dermatology. $3 669082
650 2 4 $a Pharmacotherapy. $3 973587
650 2 4 $a Primary Care Medicine. $3 673694
650 2 4 $a Public Health. $3 592982
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-28040-0
950 $a Medicine (Springer-11650)

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得

Export

取書館別